| 5BV9 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | ACT, BGC, CA, EDO, GOL, MLI | enzyme |
| ||||||||||||
| Gene | BPUM | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Strategies to reduce end-product inhibition in family 48 glycoside hydrolases., Chen M, Bu L, Alahuhta M, Brunecky R, Xu Q, Lunin VV, Brady JW, Crowley MF, Himmel ME, Bomble YJ, Proteins. 2016 Mar;84(3):295-304. doi: 10.1002/prot.24965. Epub 2016 Feb 1. PMID:26572060 | ||||||||||||||
| Data retrieval |
![]() |
| View 5BV9 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |